Moffitt is experiencing intermittent call disruptions due to a technical issue. If your call disconnects, our team will return your call using the number on file. Thank you for your patience.
A Phase 3 study to evaluate safety and efficacy of the combination of for Bel- CHOP/ Fol-COP drugs against CHOP in newly diagnosed
Peripheral T-Cell Lymphoma (blood cancer) patients
If you are interested in learning more about clinical trials, our clinical trial navigators can discuss your options and recommend opportunities that may be suitable for you. Call 813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form.
